|   |  
Corporate Profile for Lifeline BioTechnologies, dated Oct. 16, 1998 (BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. 
  Published Date:   Oct. 16, 1998
  Company Name:     Lifeline BioTechnologies
  Address:          1325 AirMotive Way, Ste 175                   Reno, NV 89502
  Main Telephone  Number:          702/852-3222
  Internet Home  Page Address   (URL)           www.LBTI.com
  Chief Executive  Officer:         Dr. Kevin Buckman
  Chief Financial  Officer:         Mr. Jim Holmes
  Investor Relations  Contact:         M & A West  Business number: 650/588-2678
  Public Relations  Contact:         M & A West  Business number: 650/588-2678
  Trading Symbol/  Exchange:        OTC BB:LBTI
  Industry:         Bio Technology
  Market Makers:    PGON, NAIB, USCT, SHRP, WIEN, PBLL, FRAN, BACH,                   SOLA, HILL
  Company description: Lifeline BioTechnologies, Inc. (Lifeline) has developed a non-invasive test for early breast cancer detection. The test is incorporated into a proprietary product called First Warning(TM). In preliminary pilot studies, First Warning(TM) demonstrated great promise in detecting formation of extremely early stage breast lesions, particularly in younger women. 
  The product collects minute temperature changes on the surface of the breast, which is a reflection of the patient's underlying physiological activity. In early studies, these changes were considered deviations for the normal core temperature of the breast. But with the utilization of neural network analysis and sophisticated algorithms, these changes were found to have definite circadian (24 hour rhythm) characteristics. The system uncovered microscopic cancer in-situ via a monitor programmed to record data from the sensors. The 9000+ data points provide a significant profile of the breast's potential health. The patient's information is downloaded, interpreted, and the results are fed back to the patient's physician. 
  The second product division under Lifeline BioTechnologies is a line of nutritional food supplements packaged and sold under the tradename NATURE'S CREATIONS. These supplements are marketed and directed towards people afflicted with degenerative diseases that are commonly found in the aging population. These diseases include cancer (breast, colon and prostate) cardiovascular, osteoporosis and mental alertness. 
  --------------------------------------------------------------------------------   |  
  |